You are here

Article Text

Article menu
Download PDFPDF
Case report
Cytomegalovirus endotheliitis with recurrent anterior uveitis and secondary glaucoma misdiagnosed as HLA-B27 uveitis
  1. Sayali Tendolkar1,
  2. Somasheila I Murthy1,
  3. Prashant Bhatia2 and
  4. Sirisha Senthil3
  1. 1Cornea Service, LV Prasad Eye Institute, Hyderabad, Telangana, India
  2. 2Department of Ophthalmology, Mediclinic Welcare Hospital, Dubai, UAE
  3. 3VST Center for Glaucoma, LV Prasad Eye Institute, Hyderabad, Telangana, India
  1. Correspondence to Dr Somasheila I Murthy; smurthy{at}lvpei.org

Abstract

A 61-year-old male patient presented with decreased vision and recurrent redness in his right eye since the past 4 years. He had been diagnosed elsewhere as HLA-B27 positive anterior uveitis and was on oral methotrexate and topical corticosteroids for recurrent disease. He was on maximal medical therapy for glaucoma. Examination showed prominent inferior corneal oedema with pigmented keratic precipitates and elevated intraocular pressure. He underwent combined trabeculectomy with mitomycin C and cataract surgery. The aqueous sample tested positive for cytomegalovirus. He responded well to oral valganciclovir with resolution of uveitis, the intraocular pressure was well controlled and the corneal oedema resolved completely.

  • anterior chamber
  • glaucoma
  • iris

https://doi.org/10.1136/bcr-2020-240061

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors Concept and design: ST and SIM. Manuscript draft: ST and SIM. Images acquisition: ST and PB. Interpretation and analysis: SIM and SS. Final manuscript: SIM, PB and SS.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent for publication Obtained.

    • Provenance and peer review Not commissioned; externally peer reviewed.